title: Visual acuity outcome in patients with diabetic maculopathy.
abstract: The purpose of this study is to follow up visual acuity in patients diagnosed with clinically significant macular edema and treated by an intravitreal injection of triamcinolone acetonide or in combination with bevacizumab. The working method: based on the selectivity criteria we involved 295 patients (460 eyes), divided into 2 groups according to the treatment administered and one control group. The results showed a better preservation of the functional parameter for the group of patients treated with intravitreal injection of triamcinolone acetonide and bevacizumab.
authors: Ophthalmology Emergency Hospital Bucharest.
authors: R
authors: R
authors: Serban
authors: Ophthalmology Emergency Hospital Bucharest.
authors: M
authors: M
authors: Cioboata
authors: Department of HIV / AIDS, Office of Ophthalmology, "Prof. Dr. Matei Bals" Institute of Infectious Diseases, Bucharest.
authors: C
authors: C
authors: Chiotan
authors: Ophthalmology Emergency Hospital Bucharest.
authors: C
authors: C
authors: Cornăcel
authors: Ophthalmology Emergency Hospital Bucharest.
authors: R
authors: R
authors: Liora
authors: Ophthalmology Emergency Hospital Bucharest.
authors: A
authors: A
authors: Anghelie
mesh_terms: D000068258:Bevacizumab / Q000008:administration & dosage; D003930:Diabetic Retinopathy / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy / Q000503:physiopathology*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage; D014792:Visual Acuity
chemical_list: D000068258:Bevacizumab; D014222:Triamcinolone Acetonide
keywords: Diabetic Maculopathy; Triamcinolone acetonide; Visual acuity; bevacizumab; clinically significant macular edema